Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of CALA opened at $0.01 on Friday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12. The business’s fifty day moving average is $0.01 and its 200-day moving average is $0.01.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.